Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Tijdschrift Voor Diergeneeskunde
|
March 15, 1977
[An atypical form of Aujezky's disease after vaccination (author's transl]
A Willemse, P R Rondhuis, S A Goedegebuure, et al.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics
|
January 7, 2003
First-order wetting transition at finite contact angle
F A M Leermakers, J H Maas, M A Cohen Stuart
Kidney International
|
March 4, 2014
Serum suPAR concentrations in patients with focal segmental glomerulosclerosis with end-stage renal disease
Rutger J H Maas, Jack F M Wetzels, Jeroen K J Deegens
Kidney International
|
May 1, 2012
Serum-soluble urokinase receptor concentration in primary FSGS
Rutger J H Maas, Jack F M Wetzels, Jeroen K J Deegens
Pediatric Nephrology (Berlin, Germany)
|
March 22, 2013
Serum suPAR in patients with FSGS: trash or treasure?
Rutger J H Maas, Jeroen K J Deegens, Jack F M Wetzels
Vox Sanguinis
|
August 31, 2002
Molecular background of Rh D-positive, D-negative, D(el) and weak D phenotypes in Chinese
C-P Shao, J-H Maas, Y-Q Su, et al.
Beitrage Zur Infusionstherapie Und Transfusionsmedizin = Contributions to Infusion Therapy and Transfusion Medicine
|
January 1, 1997
[Rh-D genotyping for exon 2, 5 and 7 of German and Japanese blood donors with sequence specific polymerase chain reaction]
J H Maas, T J Legler, R Lynen, et al.
Bone Marrow Transplantation
|
August 24, 2010
Progression of a CD4+/CD56+ blastic plasmacytoid DC neoplasm after initiation of extracorporeal photopheresis in an allogeneic transplant recipient
A Dohm, J Hasenkamp, H P Bertsch, et al.
Transfusion Medicine (Oxford, England)
|
November 7, 2001
RHD sequencing: a new tool for decision making on transfusion therapy and provision of Rh prophylaxis
T J Legler, J H Maas, M Köhler, et al.
Clinical Lung Cancer
|
November 15, 2020
Therapeutic Exposure and Successful Response to Pembrolizumab in a Patient With Non-Small-Cell Lung Cancer Despite Significant Renal Loss Due to Paraneoplastic Nephrotic Syndrome
A M E Jansen, J D Sriram, D Pluim, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Tijdschrift Voor Diergeneeskunde
|
March 15, 1977
[An atypical form of Aujezky's disease after vaccination (author's transl]
A Willemse, P R Rondhuis, S A Goedegebuure, et al.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics
|
January 7, 2003
First-order wetting transition at finite contact angle
F A M Leermakers, J H Maas, M A Cohen Stuart
Kidney International
|
March 4, 2014
Serum suPAR concentrations in patients with focal segmental glomerulosclerosis with end-stage renal disease
Rutger J H Maas, Jack F M Wetzels, Jeroen K J Deegens
Kidney International
|
May 1, 2012
Serum-soluble urokinase receptor concentration in primary FSGS
Rutger J H Maas, Jack F M Wetzels, Jeroen K J Deegens
Pediatric Nephrology (Berlin, Germany)
|
March 22, 2013
Serum suPAR in patients with FSGS: trash or treasure?
Rutger J H Maas, Jeroen K J Deegens, Jack F M Wetzels
Vox Sanguinis
|
August 31, 2002
Molecular background of Rh D-positive, D-negative, D(el) and weak D phenotypes in Chinese
C-P Shao, J-H Maas, Y-Q Su, et al.
Beitrage Zur Infusionstherapie Und Transfusionsmedizin = Contributions to Infusion Therapy and Transfusion Medicine
|
January 1, 1997
[Rh-D genotyping for exon 2, 5 and 7 of German and Japanese blood donors with sequence specific polymerase chain reaction]
J H Maas, T J Legler, R Lynen, et al.
Bone Marrow Transplantation
|
August 24, 2010
Progression of a CD4+/CD56+ blastic plasmacytoid DC neoplasm after initiation of extracorporeal photopheresis in an allogeneic transplant recipient
A Dohm, J Hasenkamp, H P Bertsch, et al.
Transfusion Medicine (Oxford, England)
|
November 7, 2001
RHD sequencing: a new tool for decision making on transfusion therapy and provision of Rh prophylaxis
T J Legler, J H Maas, M Köhler, et al.
Clinical Lung Cancer
|
November 15, 2020
Therapeutic Exposure and Successful Response to Pembrolizumab in a Patient With Non-Small-Cell Lung Cancer Despite Significant Renal Loss Due to Paraneoplastic Nephrotic Syndrome
A M E Jansen, J D Sriram, D Pluim, et al.
Page
of 2